Reneurogen

Manufacturing · Wisconsin, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

2160 San Fernando Dr, Elm Grove, Wiscons...

Phone Number

(414) 507-9144

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Reneurogen

ReNeuroGen LLC is a virtual pharmaceutical company focused on developing systems pharmacology therapies targeting neurological and pulmonary diseases. Their lead candidate, KYC, is designed to inhibit inflammation and treat conditions such as Sickle Cell Disease, Multiple Sclerosis, Brain Injury, and Bronchopulmonary Dysplasia. The company aims to create first-in-class chemico-pharmacology agents that address multi-target disease states. ReNeuroGen's innovative approach is directed towards improving patient outcomes through advanced therapeutic solutions.Explore more
Reneurogen's Social MediaPopular SearchesReNeuroGen LLCSIC Code 28,283NAICS Code 32,325Show more

Reneurogen Org Chart

SN
United States flag for contact location.

Chief Executive Officer

PhoneEmail
Billy Day, Chief Operating Officer at Reneurogen
United States flag for contact location.

Chief Operating Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Reneurogen your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Reneurogen

Compare insights from companies similar to Reneurogen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Reneurogen

<$5M
1-10
Private
-
2016
$7.1M
11-50
Private
-
2001
DS
David SolomonMedical Director
<$5M
1-10
Private
-
2003
KD
Kate DidioClinical Consultant Operations
<$5M
1-10
Private
-
2010
ST
Saifullah TanhaSenior Team Manager
<$5M
1-10
Private
-
2018
JT
James TaltonPresident & CEO
<$5M
1-10
Private
-
1997
PP
Philip PembertonChief Technical Officer
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Reneurogen is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Reneurogen is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Reneurogen.

Reneurogen Tech Stack

A closer look at the technologies used by Reneurogen

Top Manufacturing Companies

Frequently Asked Questions Regarding Reneurogen

What is Reneurogen's official website?
Reneurogen's official website is www.rngen.com
What is Reneurogen's Revenue?
Reneurogen's revenue is <$5 Million
What is Reneurogen's SIC code?
Reneurogen's SIC: 28,283
What is Reneurogen's NAICS code?
Reneurogen's NAICS: 32,325
How many employees does Reneurogen have?
Reneurogen has 1-10 employees
What industry does Reneurogen belong to?
Reneurogen is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Reneurogen competition?
Reneurogen top competitors include: Ellodi Pharmaceuticals, Nanopharmaceutics, Patagonia Pharmaceuticals, Arriva Pharmaceuticals
What technology does Reneurogen use?
Some of the popular technologies that Reneurogen uses are: Sentry, Microsoft 365, F5 BIG-IP Platform, F5 BIG-IP Application Security Manager
How do I contact Reneurogen?
Reneurogen contact info: Phone number: (414) 507-9144 Website: www.rngen.com
What does Reneurogen do?

ReNeuroGen LLC is a virtual pharmaceutical company focused on developing systems pharmacology therapies targeting neurological and pulmonary diseases. Their lead candidate, KYC, is designed to inhibit inflammation and treat conditions such as Sickle Cell Disease, Multiple Sclerosis, Brain Injury, and Bronchopulmonary Dysplasia. The company aims to... create first-in-class chemico-pharmacology agents that address multi-target disease states. ReNeuroGen's innovative approach is directed towards improving patient outcomes through advanced therapeutic solutions.Read More

What are Reneurogen social media links?
Reneurogen Linkedin page
Is Reneurogen a public company?
Reneurogen is private company therefore does not currently have an official ticker symbol
See more information about Reneurogen

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.